Stay updated on Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.

Latest updates to the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page
- Check6 days agoChange DetectedA new study site, Hospital Universitario Virgen de la Victoria, was added and the previous Hospital Virgen de la Victoria was removed. A government funding lapse notice was added to the top of the page.SummaryDifference0.4%

- Check14 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4.SummaryDifference0.1%

- Check21 days agoChange DetectedNew revision notes indicate v3.3.4 have been added along with recent update dates (Jan 2026) and older revision notes (v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedExpanded the Locations section with updated site listings across US states, Australia, and Canada, and updated the page revision to v3.3.3. Previous location blocks were replaced.SummaryDifference1%

- Check64 days agoChange DetectedDifference0.1%

- Check71 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 in the page footer; no changes to study information or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.